CrossBridge Bio

CrossBridge Bio

HealthHouston, United States

CrossBridge Bio is a Houston-based biotech startup that develops antibody-drug conjugates (ADCs) for cancer treatment. Founded in 2023, the company is notable for its innovative approach to combining targeted therapy with chemotherapy, aiming to kill cancer cells while preserving healthy tissue.

$300MVisit website ↗LinkedIn ↗

Funding history

  1. $300M2026-06-03
    Source: news.google.com ↗

Founder

Michael Torres
Michael Torres
Co-founder and CEO
LinkedIn ↗

Investors in CrossBridge Bio

Backers from this company's tracked funding rounds.

  • Texas Medical Center Venture Fund
  • CE-Ventures
  • Alexandria Venture Investments
  • Portal Innovations
  • Linden Lake Labs
  • Cancer Prevention and Research Institute of Texas

More Health companies

Recently funded startups in the same category.

Related on Datapile